Is Asthma Genetic? What Your DNA Reveals About Asthma Risk

If you grew up wheezing while your siblings breathed easy, you've probably wondered - is asthma something you inherited? The answer is a definitive yes, at least in part. Asthma is strongly genetic, with heritability estimates ranging from 35% to 90% depending on the study and population (Polderman et al., 2015). That makes it one of the most heritable common diseases, on par with type 2 diabetes and far above many conditions people assume are "purely genetic."

But having asthma genes doesn't guarantee you'll wheeze. Like most complex diseases, asthma emerges from a collision between your genetic blueprint and your environment - allergens, pollution, infections, even the microbes you encountered as an infant. Understanding the genetic side of this equation is no longer academic curiosity. It's reshaping how doctors diagnose, treat, and even prevent asthma.

How We Know Asthma Runs in Families

The evidence is overwhelming. If one of your parents has asthma, your risk of developing it is roughly three times higher than someone with unaffected parents. If both parents have asthma, that risk climbs to around 50% (Litonjua et al., 1998). But family studies alone can't separate genetics from shared environments - maybe asthmatic families just live in dustier houses.

That's where twin studies become essential. A landmark study of over 19,000 Danish twin pairs found that if one identical twin has asthma, the co-twin's risk is approximately six times higher than the general population. For fraternal twins sharing only half their DNA, the risk was about threefold (Thomsen et al., 2010). The gap between identical and fraternal twins is the genetic signal.

Multiple large-scale twin studies have converged on a heritability estimate between 55% and 90% for childhood-onset asthma, with somewhat lower estimates (35–70%) for adult-onset disease (Thomsen et al., 2010; Ullemar et al., 2016). A Swedish registry study of over 25,000 twins pegged heritability at 82% for childhood asthma specifically (Ullemar et al., 2016). These are striking numbers - they mean that the majority of variation in who gets asthma and who doesn't is written in DNA.

The Genes Behind Asthma: From ORMDL3 to IL-33

Unlike cystic fibrosis or sickle cell disease, asthma isn't caused by a single gene. It's polygenic, meaning dozens to hundreds of genetic variants each nudge your risk up or down by small amounts. Genome-wide association studies (GWAS) - which scan millions of DNA markers across thousands of people - have been the key tool for identifying these variants.

The most replicated asthma gene sits on chromosome 17q21, in a region containing ORMDL3 and GSDMB. First identified in 2007, this locus has been confirmed in virtually every large asthma GWAS since (Moffatt et al., 2007). The ORMDL3 gene encodes a protein in the endoplasmic reticulum that regulates sphingolipid synthesis and inflammatory pathways. Variants here are particularly strongly associated with childhood-onset asthma and early wheeze triggered by rhinovirus infections (Caliskan et al., 2013).

Beyond 17q21, GWAS have identified a constellation of immune-related genes:

• IL33 (interleukin-33) - an "alarm" cytokine released by damaged airway cells that triggers type 2 inflammation. Variants near IL33 are among the most robust asthma signals across ethnic groups (Torgerson et al., 2011).
• TSLP (thymic stromal lymphopoietin) - another epithelial alarm signal that activates dendritic cells and drives allergic inflammation. Anti-TSLP therapy (tezepelumab) is now an FDA-approved asthma biologic, directly validating this genetic finding (Torgerson et al., 2011).
• IL13 and IL1RL1 - key players in the type 2 inflammatory cascade. IL13 drives mucus overproduction and airway remodeling; IL1RL1 encodes the receptor for IL-33 (Demenais et al., 2018).
• HLA region (chromosome 6p21) - the human leukocyte antigen complex, which governs immune recognition. Multiple HLA variants influence asthma and allergy susceptibility (Demenais et al., 2018).

The largest multi-ancestry GWAS meta-analysis to date, published in 2023, identified 179 genome-wide significant loci for asthma across diverse populations - nearly doubling the number of known risk regions (Han et al., 2023). Many of these genes converge on two biological themes: epithelial barrier function (how well your airway lining keeps irritants out) and type 2 immune regulation (how aggressively your immune system responds to allergens).

What Your Genetic Results Actually Mean

If you've had DNA testing through 23andMe, AncestryDNA, or a clinical panel, you might wonder what your results say about asthma risk. Here's how to interpret the key findings:

• ORMDL3/17q21 variants (e.g., rs8076131, rs7216389) - Risk alleles are common (carried by 40–60% of people of European descent). Having one or two copies modestly increases childhood asthma risk, typically by 20–40% per allele (Moffatt et al., 2007).
• IL33 variants (e.g., rs1342326) - Associated with both asthma susceptibility and blood eosinophil counts. Higher eosinophils often predict better response to biologic therapies (Aneas et al., 2021).
• ADRB2 variants (e.g., rs1042713, Arg16Gly) - This gene encodes the beta-2 adrenergic receptor, the target of albuterol and other rescue inhalers. The Gly16 variant is associated with faster receptor downregulation and potentially reduced long-term response to regular beta-agonist use (Hikino et al., 2021).
• ADRB2 Glu27Gln (rs1042714) - Another common variant affecting receptor function, though its clinical impact remains debated (Drysdale et al., 2000).

Important context: Each individual variant contributes only a small amount of risk. A polygenic risk score (PRS) - which combines the effects of thousands of variants into a single number - provides a much more complete picture. Research-grade asthma PRS can now identify individuals in the top 10% of genetic risk who have a 2–3 fold higher likelihood of developing asthma compared to average (Dijk et al., 2021).

You can explore your genetic variants related to asthma and hundreds of other conditions by uploading your raw DNA data to GenomeInsight.

Genetics vs. Environment: The Full Picture

Genes load the gun, but environment pulls the trigger. Even with high genetic risk, asthma requires environmental exposures to manifest. Key environmental factors that interact with genetic susceptibility include:

• Early respiratory infections - Rhinovirus wheezing in infancy, particularly in children carrying 17q21 risk alleles, strongly predicts persistent asthma (Caliskan et al., 2013)
• Air pollution - Particulate matter and nitrogen dioxide exposure amplify genetic risk, especially in urban environments (Guarnieri & Balmes, 2014)
• Allergen exposure - Dust mites, pet dander, and mold in early life can trigger sensitization in genetically predisposed children
• Microbiome - Children raised on farms or exposed to diverse microbes early in life have lower asthma rates, even with genetic risk factors - the so-called "farm effect" (Ege et al., 2011)
• Tobacco smoke - Maternal smoking during pregnancy and secondhand smoke exposure interact with genetic variants to dramatically increase childhood asthma risk

This gene-environment interplay explains why asthma rates vary so much between countries and have risen sharply over decades - our genes haven't changed, but our environments have.

What You Can Do With This Information

Understanding your genetic asthma risk isn't just academic - it can guide real decisions:

For prevention:

• If you carry high-risk variants and are planning a family, minimizing tobacco smoke exposure and considering breastfeeding may help lower your child's risk
• Early intervention during viral wheezing episodes in high-risk infants may prevent progression to persistent asthma

For treatment:

• ADRB2 genotyping can help predict your response to beta-agonist inhalers. If you carry the Gly16 variant, your doctor might consider alternative controller medications or closer monitoring of rescue inhaler effectiveness (Finkelstein et al., 2009)
• Eosinophil-related variants (near IL33, IL13, TSLP) may predict better response to biologic therapies like dupilumab, mepolizumab, or tezepelumab
• Pharmacogenomic insights from your DNA can complement standard pulmonary function tests - learn more about how pharmacogenomics works

For understanding:

• A comprehensive DNA health report can contextualize your asthma genetics alongside related traits like allergies, eczema, and immune function
• Knowing your genetic risk can motivate evidence-based environmental modifications rather than anxiety

Key Takeaways

• Asthma is highly heritable - twin studies estimate 55–90% of susceptibility is genetic, making it one of the most heritable common diseases
• 179+ genetic loci have been identified through GWAS, with key genes including ORMDL3, IL33, TSLP, IL13, and ADRB2
• No single gene causes asthma - it's polygenic, and environment plays a critical role in whether genetic risk becomes clinical disease
• Your ADRB2 genotype may influence how well you respond to rescue inhalers like albuterol
• Genetic testing can inform treatment - from predicting biologic therapy response to guiding inhaler selection
• Upload your existing DNA data to GenomeInsight to explore your asthma-related variants, or check our pricing for a full health analysis
• Stay updated on the latest genomics research through our newsletter

References

Aneas, I., Decker, D. C., Howard, C. L., Sobreira, D. R., Sakabe, N. J., Ogez, K. F., ... & Bhatt, D. K. (2021). Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region. Nature Communications, 12(1), 6115. https://doi.org/10.1038/s41467-021-26347-z

Caliskan, M., Bochkov, Y. A., Kreiner-Møller, E., Bønnelykke, K., Stein, M. M., Du, G., ... & Ober, C. (2013). Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. New England Journal of Medicine, 368(15), 1398–1407. https://doi.org/10.1056/NEJMoa1211592

Demenais, F., Margaritte-Jeannin, P., Barnes, K. C., Cookson, W. O., Altmüller, J., Ang, W., ... & Nicolae, D. L. (2018). Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nature Genetics, 50(1), 42–53. https://doi.org/10.1038/s41588-017-0014-7

Dijk, F. N., Folkersma, C., Gruber, S., Koppelman, G. H., & Vonk, J. M. (2021). Polygenic risk scores for asthma in a large birth cohort. Journal of Allergy and Clinical Immunology, 147(2), AB93. https://doi.org/10.1016/j.jaci.2020.12.340

Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K., ... & Liggett, S. B. (2000). Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proceedings of the National Academy of Sciences, 97(19), 10483–10488. https://doi.org/10.1073/pnas.97.19.10483

Ege, M. J., Mayer, M., Normand, A. C., Genuneit, J., Cookson, W. O., Braun-Fahrländer, C., ... & von Mutius, E. (2011). Exposure to environmental microorganisms and childhood asthma. New England Journal of Medicine, 364(8), 701–709. https://doi.org/10.1056/NEJMoa1007302

Finkelstein, Y., Garcia Bournissen, F., Hutson, J. R., & Shannon, M. (2009). Polymorphism of the ADRB2 gene and response to inhaled beta-agonists in children with asthma: A meta-analysis. Journal of Asthma, 46(9), 900–905. https://doi.org/10.3109/02770900903199961

Guarnieri, M., & Balmes, J. R. (2014). Outdoor air pollution and asthma. The Lancet, 383(9928), 1581–1592. https://doi.org/10.1016/S0140-6736(14)60617-6

Han, Y., Jia, Q., Jahani, P. S., Hurrell, B. P., Pan, C., Huang, P., ... & Akbari, O. (2023). Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity. Cell Genomics, 3(2), 100212. https://doi.org/10.1016/j.xgen.2022.100212

Hikino, K., Susa, S., & Kinoshita, T. (2021). A meta-analysis of the influence of ADRB2 genetic polymorphisms on albuterol (salbutamol) therapy in patients with asthma. British Journal of Clinical Pharmacology, 87(4), 1708–1716. https://doi.org/10.1111/bcp.14570

Litonjua, A. A., Carey, V. J., Burge, H. A., Weiss, S. T., & Gold, D. R. (1998). Parental history and the risk for childhood asthma. American Journal of Respiratory and Critical Care Medicine, 158(1), 176–181. https://doi.org/10.1164/ajrccm.158.1.9710014

Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., ... & Cookson, W. O. (2007). Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature, 448(7152), 470–473. https://doi.org/10.1038/nature06014

Polderman, T. J., Benyamin, B., de Leeuw, C. A., Sullivan, P. F., van Bochoven, A., Visscher, P. M., & Posthuma, D. (2015). Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nature Genetics, 47(7), 702–709. https://doi.org/10.1038/ng.3285

Thomsen, S. F., van der Sluis, S., Kyvik, K. O., Skytthe, A., & Backer, V. (2010). Estimates of asthma heritability in a large twin sample. Clinical & Experimental Allergy, 40(7), 1054–1061. https://doi.org/10.1111/j.1365-2222.2010.03525.x

Torgerson, D. G., Ampleford, E. J., Chiu, G. Y., Gauderman, W. J., Gignoux, C. R., Graves, P. E., ... & Nicolae, D. L. (2011). Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nature Genetics, 43(9), 887–892. https://doi.org/10.1038/ng.888

Ullemar, V., Magnusson, P. K., Lundholm, C., Zettergren, A., Melén, E., Lichtenstein, P., & Almqvist, C. (2016). Heritability and confirmation of genetic association studies for childhood asthma in twins. Allergy, 71(2), 230–238. https://doi.org/10.1111/all.12783

---

Related Reading

• alpha-1 antitrypsin deficiency
• psoriasis genetics
• polygenic risk scores